Cargando…
Candidate for a live vaccine?
Immune dysfunction is a well-known phenomenon in end-stage liver disease (ESLD). The pretransplant period offers a unique window for primary care physicians to optimize the transplant's vaccine protection before antirejection medications are initiated. Live vaccinations are selected cautiously...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749104/ https://www.ncbi.nlm.nih.gov/pubmed/29302565 http://dx.doi.org/10.4103/jfmpc.jfmpc_67_17 |
_version_ | 1783289532393717760 |
---|---|
author | Abbatemarco, Justin Ralph Taege, Alan |
author_facet | Abbatemarco, Justin Ralph Taege, Alan |
author_sort | Abbatemarco, Justin Ralph |
collection | PubMed |
description | Immune dysfunction is a well-known phenomenon in end-stage liver disease (ESLD). The pretransplant period offers a unique window for primary care physicians to optimize the transplant's vaccine protection before antirejection medications are initiated. Live vaccinations are selected cautiously but the varicella-zoster virus (VZV) vaccine, Zostavax, is recommended for pretransplant candidates. This case highlights an ESLD patient who developed disseminated cutaneous VZV within 30 days of vaccination. |
format | Online Article Text |
id | pubmed-5749104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-57491042018-01-04 Candidate for a live vaccine? Abbatemarco, Justin Ralph Taege, Alan J Family Med Prim Care Case Report Immune dysfunction is a well-known phenomenon in end-stage liver disease (ESLD). The pretransplant period offers a unique window for primary care physicians to optimize the transplant's vaccine protection before antirejection medications are initiated. Live vaccinations are selected cautiously but the varicella-zoster virus (VZV) vaccine, Zostavax, is recommended for pretransplant candidates. This case highlights an ESLD patient who developed disseminated cutaneous VZV within 30 days of vaccination. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5749104/ /pubmed/29302565 http://dx.doi.org/10.4103/jfmpc.jfmpc_67_17 Text en Copyright: © 2017 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Abbatemarco, Justin Ralph Taege, Alan Candidate for a live vaccine? |
title | Candidate for a live vaccine? |
title_full | Candidate for a live vaccine? |
title_fullStr | Candidate for a live vaccine? |
title_full_unstemmed | Candidate for a live vaccine? |
title_short | Candidate for a live vaccine? |
title_sort | candidate for a live vaccine? |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749104/ https://www.ncbi.nlm.nih.gov/pubmed/29302565 http://dx.doi.org/10.4103/jfmpc.jfmpc_67_17 |
work_keys_str_mv | AT abbatemarcojustinralph candidateforalivevaccine AT taegealan candidateforalivevaccine |